marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-06-2024
Surgery Partners Income Statement 2011-2024 | SGRY
Annual Income Statement Surgery Partners
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
3.81 B | 3.12 B | 3.79 B | 1.93 B | 817 M | 618 M | 764 M | 872 M | 581 M | - | - | - | - |
Shares |
126 M | 92 M | 72.4 M | 48.8 M | 48.3 M | 48 M | 48.2 M | 48 M | 36.1 M | - | - | - | - |
Historical Prices |
30.3 | 33.9 | 52.3 | 39.5 | 16.4 | 12.5 | 15.8 | 22.5 | 13.1 | - | - | - | - |
Net Income |
-11.9 M | -54.6 M | -70.9 M | -116 M | -74.8 M | -206 M | -53 M | 9.45 M | 1.43 M | -65.9 M | -9.06 M | 1.92 M | - |
Revenue |
2.74 B | 2.54 B | 2.23 B | 1.86 B | 1.83 B | 1.77 B | 1.34 B | 1.15 B | 960 M | 403 M | 285 M | 260 M | - |
Cost of Revenue |
794 M | 746 M | 644 M | 550 M | 1.41 B | 1.36 B | - | 821 M | 669 M | 254 M | 170 M | - | - |
Gross Profit |
- | - | - | - | 424 M | 410 M | 327 M | 324 M | 291 M | 149 M | 115 M | 101 M | - |
Operating Income |
328 M | 345 M | 302 M | 183 M | 236 M | 77.8 M | - | 196 M | 145 M | 50.8 M | 58.2 M | - | - |
Interest Expense |
8.6 M | 1.5 M | -200 K | - | - | - | - | - | - | - | - | - | - |
EBITDA |
446 M | 460 M | 401 M | 278 M | 337 M | 320 M | 223 M | 240 M | 213 M | 112 M | 82.2 M | 72.5 M | - |
Operating Expenses |
2.42 B | 2.19 B | 1.92 B | 1.68 B | 164 M | 157 M | 156 M | 124 M | 112 M | 52.7 M | 44.2 M | 39.6 M | - |
General and Administrative Expenses |
121 M | 102 M | 104 M | 97.1 M | 88.6 M | 93.6 M | 76 M | 60.2 M | 56 M | 31.5 M | 26.3 M | 25.3 M | - |
All numbers in USD currency
Quarterly Income Statement Surgery Partners
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
126 M | 126 M | 127 M | 126 M | 126 M | 125 M | 126 M | 88.9 M | 88.9 M | 88 M | 89.3 M | 80.7 M | 69.3 M | 54.8 M | 50.5 M | 48.9 M | 48.8 M | 48.5 M | 49.3 M | 48.3 M | 48.3 M | 48 M | 48.9 M | 48 M | 48 M | 48 M | 48.3 M | 48.3 M | 48.1 M | 48 M | 48.5 M | 48 M | 48 M | 48 M | 48.2 M | 32.1 M | 32.1 M | 32.1 M | 1 K | 31.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-15.5 M | -12.4 M | - | -4.9 M | 18.9 M | -24.9 M | - | -25 M | -18.4 M | 12.2 M | - | -22.9 M | -26.9 M | -21 M | - | -61.6 M | -32.5 M | -27.5 M | -19.2 M | -15.7 M | -19.8 M | -20.1 M | -148 M | -21 M | -19.5 M | -17.5 M | -32.2 M | -9.14 M | -4.47 M | -2.75 M | 16.9 M | -2.34 M | 2.12 M | -7.19 M | 16.7 M | -3.12 M | -5.43 M | -6.76 M | -54.3 M | -6.91 M | -606 K | -4.12 M | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
762 M | 717 M | - | 674 M | 668 M | 666 M | - | 621 M | 615 M | 596 M | - | 2.9 M | 3 M | 2.6 M | - | 3.1 M | 2.5 M | 2 M | 517 M | 2.4 M | 2.2 M | 2 M | 491 M | 1.9 M | 2.5 M | 417 M | 460 M | 712 K | 288 M | 286 M | 306 M | 283 M | 290 M | 267 M | 263 M | 240 M | 233 M | 224 M | 180 M | 76.3 M | 76.8 M | 70.5 M | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
223 M | 215 M | - | 195 M | 195 M | 202 M | - | 186 M | 182 M | 179 M | - | 162 M | 155 M | 152 M | - | 142 M | 116 M | 140 M | 388 M | 353 M | 340 M | 326 M | 360 M | 334 M | 340 M | 327 M | 339 M | 103 M | 216 M | 212 M | 214 M | 201 M | 209 M | 197 M | 183 M | 169 M | 162 M | 156 M | 121 M | 45.4 M | 45.2 M | 43 M | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
84.8 M | 76 M | - | 82.6 M | 97.6 M | 46.4 M | - | 74.1 M | 76.5 M | 100 M | - | 63.6 M | 59.5 M | 64.3 M | - | 18.5 M | 44.7 M | 23.5 M | - | 59 M | 55.5 M | 49.6 M | - | 45 M | 43.5 M | 41.2 M | 92.3 M | 11.9 M | 37.7 M | 41.7 M | - | 42.8 M | 50.9 M | 34.3 M | - | 44.3 M | 41 M | 38.4 M | - | 19.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-4.8 M | 400 K | - | 1.2 M | 6.5 M | - | - | 1.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
120 M | 110 M | - | 112 M | 122 M | 80.1 M | - | 104 M | 104 M | 128 M | - | 88.8 M | 84.7 M | 90 M | - | 42.6 M | 68.1 M | 45.3 M | - | 77.4 M | 74.6 M | 68.4 M | - | 62 M | 60.2 M | 56.9 M | 114 M | 15.3 M | 49.2 M | 52.8 M | - | 52.6 M | 60.6 M | 43.8 M | - | 52.9 M | 49.5 M | 46.8 M | - | 22.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
677 M | 641 M | - | 592 M | 570 M | 620 M | - | 546 M | 539 M | 496 M | - | 496 M | 484 M | 448 M | - | 478 M | 330 M | 418 M | - | 393 M | 390 M | 367 M | - | 387 M | 393 M | 370 M | 500 M | 120 M | 251 M | 244 M | - | 240 M | 239 M | 233 M | - | 195 M | 192 M | 186 M | - | 56.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
40.3 M | 33.2 M | - | 36.8 M | 31.2 M | 32 M | - | 17.9 M | 26.1 M | 29.5 M | - | 25.5 M | 24.5 M | 26.8 M | - | 25.2 M | 25.3 M | 22.8 M | - | 19.9 M | 23.3 M | 21.7 M | - | 19.4 M | 26.1 M | 24.2 M | 29.2 M | 7.78 M | 18.7 M | 15.5 M | - | 15 M | 15 M | 12.2 M | - | 11.2 M | 11.8 M | 11.9 M | - | 6.74 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency